
Pitcher Zach Penrod, who made seven starts with the Portland Sea Dogs at the start of the last season, had on MRI on Wednesday because of elbow soreness. Shawn Patrick Ouellette/Staff Photographer
FORT MYERS, Fla. — Red Sox lefty Zach Penrod underwent an MRI on Wednesday after experiencing soreness in his elbow, manager Alex Cora said Thursday.
Penrod is on the 40-man roster after making his major-league debut late in 2024. A source said those involved are “not optimistic” while they await details from the exam, signaling concern about potential ligament damage that could lead to a long absence.
“We’re waiting for the results. We’ll know more tomorrow,” Cora said.
Penrod was listed among the non-throwing pitchers in camp Thursday after first feeling the injury while throwing a couple days ago.
The Red Sox signed Penrod out of independent baseball in August 2023. He pitched seven games after making his debut in September last season. In four innings, he allowed two runs (one earned) on three hits, while walking four and striking out three. He started the season with the Portland Sea Dogs, making seven starts. In 35 1/3 innings, he allowed 23 hits and 11 earned runs. He also made 15 appearances for Triple-A Worcester, including five starts.
“Hopefully everything’s OK,” Cora said. “With the lefties, we’ve got (Aroldis Chapman), we’ve got (Justin) Wilson. We’ve got (Brennan Bernardino). We’ve got Penrod. There’s probably more coming in the upcoming days. We felt like the last few years we had good ones but we were short. So like I said, competition is good. The more the better. (Penrod) is part of the equation.”
THE RED SOX are signing 35-year-old veteran left-handed pitcher Matt Moore to a minor league contract, according to a source.
Moore can opt out of the contract five days before Opening Day if Boston doesn’t add him to its 40-man roster. That’s the case with all veteran free agents who sign non-guaranteed deals, including fellow veteran Adam Ottavino, who re-joined the Sox earlier this week.
Moore, who was selected to the AL All Star team and finished ninth for the Cy Young in 2013, struggled on a one-year, $9 million contract with the Angels last season. He recorded a 5.03 ERA, 1.34 WHIP, 41 strikeouts and 26 walks in 51 relief outings (48 1/3 innings). He did hold opponents to a .218 batting average. Left-handed hitters hit just .174 against him. Moore’s season ended a month early due to a forearm strain but he appears to be healthy now.
Moore has a career 4.39 ERA in 369 outings, including 164 starts. He has a 3.64 in 205 relief outings.
Send questions/comments to the editors.
Join the Conversation
We believe it’s important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It’s a form of open discourse that can be useful to our community, public officials, journalists and others. Read more...
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
For those stories that we do enable discussion, our system may hold up comments pending the approval of a moderator for several reasons, including possible violation of our guidelines. As the Maine Trust’s digital team reviews these comments, we ask for patience.
Comments are managed by our staff during regular business hours Monday through Friday and limited hours on Saturday and Sunday. Comments held for moderation outside of those hours may take longer to approve.
By joining the conversation, you are agreeing to our commenting policy and terms of use. More information is found on our FAQs.
You can modify your screen name here.
Show less
Join the Conversation
Please sign into your CentralMaine.com account to participate in conversations below. If you do not have an account, you can register or subscribe. Questions? Please see our FAQs.